- Home
- SFD vs VRNA Comparison
SFD vs VRNA Comparison
Compare SFD & VRNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SFD
- VRNA
- Stock Information
- Founded
- SFD 1936
- VRNA 2005
- Country
- SFD United States
- VRNA United Kingdom
- Employees
- SFD N/A
- VRNA N/A
- Industry
- SFD
- VRNA Biotechnology: Pharmaceutical Preparations
- Sector
- SFD
- VRNA Health Care
- Exchange
- SFD NYSE
- VRNA Nasdaq
- Market Cap
- SFD 7.7B
- VRNA 7.8B
- IPO Year
- SFD 2025
- VRNA 2017
- Fundamental
- Price
- SFD $23.35
- VRNA $92.20
- Analyst Decision
- SFD Strong Buy
- VRNA Strong Buy
- Analyst Count
- SFD 5
- VRNA 7
- Target Price
- SFD $28.60
- VRNA $97.57
- AVG Volume (30 Days)
- SFD 452.7K
- VRNA 1.4M
- Earning Date
- SFD 07-29-2025
- VRNA 08-07-2025
- Dividend Yield
- SFD 2.14%
- VRNA N/A
- EPS Growth
- SFD 16.88
- VRNA N/A
- EPS
- SFD 2.67
- VRNA N/A
- Revenue
- SFD $14,469,000,000.00
- VRNA $118,535,000.00
- Revenue This Year
- SFD $7.21
- VRNA $891.79
- Revenue Next Year
- SFD $0.34
- VRNA $78.94
- P/E Ratio
- SFD $8.75
- VRNA N/A
- Revenue Growth
- SFD N/A
- VRNA N/A
- 52 Week Low
- SFD $18.43
- VRNA $14.14
- 52 Week High
- SFD $24.07
- VRNA $94.45
- Technical
- Relative Strength Index (RSI)
- SFD N/A
- VRNA 78.05
- Support Level
- SFD N/A
- VRNA $82.18
- Resistance Level
- SFD N/A
- VRNA $93.74
- Average True Range (ATR)
- SFD 0.00
- VRNA 3.21
- MACD
- SFD 0.00
- VRNA 0.89
- Stochastic Oscillator
- SFD 0.00
- VRNA 92.52
About SFD SMITHFIELD FOODS INC
Smithfield Foods Inc is a hog producer and pork processor based in the United States of America. The company conducts its operations through three reportable segments: Packaged Meats, Fresh Pork, and Hog Production. The company generates the majority of its revenue from the Packaged Meats segment. The Packaged Meats segment consists of the company's U.S. operations that process fresh meat into a wide variety of packaged meats products, including bacon, sausage, hot dogs, deli and lunch meats, dry sausage products (such as pepperoni and genoa), ham products, ready-to-eat products and prepared foods (such as pre-cooked entrees, bacon and sausage).
About VRNA Verona Pharma plc
Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.